- Home
- MNKD vs GRAL Comparison
MNKD vs GRAL Comparison
Compare MNKD & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNKD
- GRAL
- Stock Information
- Founded
- MNKD 1991
- GRAL 2016
- Country
- MNKD United States
- GRAL United States
- Employees
- MNKD N/A
- GRAL N/A
- Industry
- MNKD Biotechnology: Pharmaceutical Preparations
- GRAL
- Sector
- MNKD Health Care
- GRAL
- Exchange
- MNKD Nasdaq
- GRAL NYSE
- Market Cap
- MNKD 1.4B
- GRAL 1.3B
- IPO Year
- MNKD 2004
- GRAL N/A
- Fundamental
- Price
- MNKD $3.75
- GRAL $49.38
- Analyst Decision
- MNKD Buy
- GRAL Buy
- Analyst Count
- MNKD 4
- GRAL 3
- Target Price
- MNKD $9.75
- GRAL $31.50
- AVG Volume (30 Days)
- MNKD 3.2M
- GRAL 1.5M
- Earning Date
- MNKD 08-06-2025
- GRAL 08-12-2025
- Dividend Yield
- MNKD N/A
- GRAL N/A
- EPS Growth
- MNKD 228.27
- GRAL N/A
- EPS
- MNKD 0.10
- GRAL N/A
- Revenue
- MNKD $297,595,000.00
- GRAL $130,711,000.00
- Revenue This Year
- MNKD $13.72
- GRAL $19.52
- Revenue Next Year
- MNKD $15.21
- GRAL $20.37
- P/E Ratio
- MNKD $35.96
- GRAL N/A
- Revenue Growth
- MNKD 32.50
- GRAL 30.47
- 52 Week Low
- MNKD $3.63
- GRAL $12.33
- 52 Week High
- MNKD $7.63
- GRAL $63.99
- Technical
- Relative Strength Index (RSI)
- MNKD 35.30
- GRAL N/A
- Support Level
- MNKD $3.65
- GRAL N/A
- Resistance Level
- MNKD $4.00
- GRAL N/A
- Average True Range (ATR)
- MNKD 0.15
- GRAL 0.00
- MACD
- MNKD 0.00
- GRAL 0.00
- Stochastic Oscillator
- MNKD 12.16
- GRAL 0.00
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.